NCT05338047 Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant Status COMPLETED Phase PHASE2
NCT05320081 Camrelizumab Combined With CD30 CAR-T in the Treatment of Relapsed/Refractory CD30+ Lymphoma Status UNKNOWN Phase PHASE2
NCT05294367 Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma Status RECRUITING Phase EARLY_PHASE1
NCT05294055 Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma Status RECRUITING Phase PHASE2
NCT05293912 SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma. Status TERMINATED Phase PHASE1
NCT05275036 Assessment of Early-detection Based on Liquid Biopsy in Lymphoid Malignancies Status UNKNOWN Phase N/A
NCT05274763 Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant Status COMPLETED Phase NA
NCT05257785 Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors Status RECRUITING Phase NA
NCT05250869 Comparative Quantification of MTX and Its Metabolites Post Glucarpidase Status COMPLETED Phase N/A
NCT05244070 A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status TERMINATED Phase PHASE1
NCT05239676 Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma Status UNKNOWN Phase EARLY_PHASE1
NCT05237986 Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy Status RECRUITING Phase N/A
NCT05223413 REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs Status RECRUITING Phase NA